Ignite Creation Date:
2025-12-25 @ 3:37 AM
Ignite Modification Date:
2025-12-26 @ 2:20 AM
Study NCT ID:
NCT06103305
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-07-30
First Post:
2023-10-22
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Risk Stratifications for Patients With Palpitations
Sponsor:
Assiut University
Organization:
Study Overview
Official Title:
Risk Stratifications for Patients Come With Palpitations in Assiut and Suez Canal University Hospitals
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
the aim of the study is to early diagnose and early proper mangment of those patients who have palpitations specially of cardiac origin
Detailed Description:
Palpitation : are one of the most common presentations to general practice, and while they are usually benign, they may also have life-threatening significance. Palpitations have been estimated to account for 16% of general practice presentations and are the second most common presentation to cardiologists after chest pain.
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: